Cornerstone Advisors (Washington)’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-791
| Closed | -$248K | – | 1244 |
|
|
2019
Q2 | $248K | Sell |
791
-51
| -6% | -$16K | 0.02% | 116 |
|
|
2019
Q1 | $346K | Buy |
842
+30
| +4% | +$12.3K | 0.03% | 76 |
|
|
2018
Q4 | $303K | Buy |
812
+136
| +20% | +$50.7K | 0.05% | 78 |
|
|
2018
Q3 | $273K | Buy |
676
+9
| +1% | +$3.64K | 0.18% | 90 |
|
|
2018
Q2 | $230K | Sell |
667
-1
| -0.1% | -$345 | 0.16% | 104 |
|
|
2018
Q1 | $230K | Buy |
668
+22
| +3% | +$7.58K | 0.16% | 102 |
|
|
2017
Q4 | $243K | Sell |
646
-77
| -11% | -$29K | 0.16% | 90 |
|
|
2017
Q3 | $323K | Sell |
723
-20
| -3% | -$8.94K | 0.22% | 68 |
|
|
2017
Q2 | $365K | Sell |
743
-90
| -11% | -$44.2K | 0.2% | 54 |
|
|
2017
Q1 | $323K | Buy |
833
+165
| +25% | +$64K | 0.18% | 62 |
|
|
2016
Q4 | $245K | Buy |
668
+20
| +3% | +$7.34K | 0.21% | 74 |
|
|
2016
Q3 | $261K | Buy |
648
+305
| +89% | +$123K | 0.22% | 63 |
|
|
2016
Q2 | $120K | Sell |
343
-65
| -16% | -$22.7K | 0.12% | 90 |
|
|
2016
Q1 | $147K | Buy |
408
+18
| +5% | +$6.49K | 0.15% | 85 |
|
|
2015
Q4 | $212K | Sell |
390
-420
| -52% | -$228K | 0.23% | 53 |
|
|
2015
Q3 | $377K | Sell |
810
-30
| -4% | -$14K | 0.33% | 36 |
|
|
2015
Q2 | $429K | Sell |
840
-130
| -13% | -$66.4K | 0.35% | 40 |
|
|
2015
Q1 | $438K | Hold |
970
| – | – | 0.34% | 42 |
|
|
2014
Q4 | $398K | Buy |
970
+915
| +1,664% | +$375K | 0.29% | 54 |
|
|
2014
Q3 | $20K | Sell |
55
-4
| -7% | -$1.46K | 0.02% | 133 |
|
|
2014
Q2 | $17K | Hold |
59
| – | – | 0.02% | 161 |
|
|
2014
Q1 | $18K | Buy |
+59
| New | +$18K | 0.02% | 144 |
|